| References |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Self Improvement > Stress Management > Crisis Intervention – What To Do in the Event of a Crisis? Part 1 |
|
References - Crisis Intervention – What To Do in the Event of a Crisis? Part 1
More so than in other counselling situation, in crisis counselling the social worker or counsell According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product or has the obligation to apply a more directive approach in order to ke ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ep the client safe, move her away from the crisis situation where immi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ent danger might be present, and enable her to take advantage of the resources. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe The following story is a good an analogy for crisis counselling: She reached a point wher d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e the fog was so strong there was no way she could go further. Then it started to snow and slowl ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the night fell in around her. She was in an uncomfortable space, unable to make any move. The e easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ffort of just staying alive was almost too difficult. The only thing she could do was to send ou nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t her last signal rocket in a desperate cry for help. After seemingly never-ending hours the new and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ day set in and she came to realise that she wasn’t really as stuck as she had thought she was. T ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi he fog lifted its veil and she now clearly saw the valley in front of her, the house she had bee ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a n looking for and the path leading down to it. The way finally became clear and safe to go forwa dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d again. We need to recognise the ‘signal rocket’ that a client is sending out, move her o cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ut of the ‘darkness of the night’, help her see the house in the distance and plan her way home. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Still referring to the analogy, the ‘snow’ and the ‘darkness of the night’ represent the client t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s perception of the crisis. These images suggest that although we might not notice the items/iss ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ues that obstruct her sight, we are required to accept her viewpoint. In realit y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products y, the whole set of intervention steps can only work when we establish a trusting, under . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tanding and solid relationship with the client. A crisis is a window of opportunity fo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip r spiritual growth. You don’t need to be a social worker or counsellor to assist someone in need tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Are You Considering A Vasectomy? Being Authentic - How Can You Be Who You Really Are
|